Table 4.
Unadjusted | Adjusted for age, sex, chronic disease | Adjusted for sex, chronic disease, SAPS II* | |||||||
OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
Nitrite | |||||||||
Low (≤1.49 μmol/L) | 1 | 1 | 1 | ||||||
High (>1.49 μmol/L) | 2.20 | 0.62–7.85 | 0.22 | 1.87 | 0.50–6.93 | 0.35 | 4.60 | 0.92–23.03 | 0.06 |
l-Arginine | |||||||||
High (>71.98 μmol/L) | 1 | 1 | 1 | ||||||
Low (≤71.98 μmol/L) | 0.59 | 0.23–1.54 | 0.28 | 0.56 | 0.21–1.48 | 0.24 | 0.61 | 0.18–2.06 | 0.43 |
ADMA | |||||||||
Low (≤0.40 μmol/L) | 1 | 1 | 1 | ||||||
High (>0.40 μmol/L) | 11.5 | 1.50–88.41 | 0.02 | 10.23 | 1.32–79.38 | 0.03 | 13.17 | 0.91–191 | 0.06 |
l-Arginine/ADMA ratio | |||||||||
High (>101.59) | 1 | 1 | 1 | ||||||
Low (≤101.59) | 5.76 | 1.85–17.90 | 0.003 | 5.02 | 1.59–15.91 | 0.006 | 6.03 | 1.41–25.84 | 0.016 |
*Five patients were not included in the analysis due to missing data of SAPS II (one of whom died the first day of admission). When the missing variables were replaced with the minimal value and maximum value, the median SAPS II was 27 (18–44) and 37 (30–54), respectively. Age is included in SAPS II. Optimal cutoff was found by the maximum sum of sensitivity and specificity.
ADMA indicates asymmetric dimethylarginine; CI, confidence interval; OR, odds ratio; SAPS II, Simplified Acute Physiology Score II.